Get started
Author

Carol A. Duncan

Observed names: C A Duncan, C. A. H. Duncan, C.A. Duncan, C.A.H. Duncan
OpenAlex ID: A5083045215
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
1990 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 247
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
1990 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 154
The physiological disposition of lovastatin.
1989 · D E Duggan, I W Chen, et al. · Drug Metabolism and Disposition · 124
Carnitine and glucuronic acid conjugates of pivalic acid
1985 · S. Vickers, C. A. H. Duncan, et al. · Xenobiotica · 42
Metabolic disposition of simvastatin in patients with T-tube drainage.
1994 · H Cheng, M S Schwartz, et al. · Drug Metabolism and Disposition · 38
In Vitro and In Vivo Studies on the Metabolism of Tirofiban
1999 · Stanley Vickers, Anthony D. Theoharides, et al. · Drug Metabolism and Disposition · 36
Evaluation of Succinimidoethyl and Pivaloyloxyethyl Esters as Progenitors of Methyldopa in Man, Rhesus Monkey, Dog, and Rat
1978 · S. Vickers, C.A. Duncan, et al. · Drug Metabolism and Disposition · 27
In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
1993 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 9
Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
1998 · S Vickers, C A Duncan, et al. · PubMed · 8
Studies on the metabolic inversion of the 6′ chiral center or simvastatin
1991 · Stanley Vickers, Carol A. Duncan · Biochemical and Biophysical Research Communications · 7
Metabolism of the TRH analog L-pyro-2-aminoadipyl-L-histidyl-[3H]-L-thiazolidine-4-carboxamide (MK-771) in gut and brain tissue of rats: the implications for its bioavailability.
1983 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 4
Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs.
1994 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 3
The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
1980 · S Vickers, C A Duncan, et al. · Drug Metabolism and Disposition · 1
GLC Determination of S-2-(3-tert-Butylamino-2-hydroxypropoxy)-3-cyanopyridine in Human Plasma
1979 · S. Vickers, C.A.H. Duncan · Journal of Pharmaceutical Sciences · 1
Works count: 16
Citation count: 701
H-index: 8
I10-index: 7
Year
Topic
Type